subscribeSubscribe
Novo Nordisk`s Ozempic cuts dementia risk vs. Merck`s Januvia

Novo Nordisk`s Ozempic cuts dementia risk vs. Merck`s Januvia
Kevin Dunleavy FIERCE PHARMA
12 Jul 2024
Share Share
Activist demands regulatory probe overcharging of diabetic drug Janumet by MSD

Activist demands regulatory probe overcharging of diabetic drug Janumet by MSD
PHARMABIZ
02 Apr 2024
Share Share
Ami successful filing of the USDMF for Sitagliptin Phosphate Monohydrate

Ami successful filing of the USDMF for Sitagliptin Phosphate Monohydrate
PRESS RELEASE
23 Jan 2024
Share Share
NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of DA-1241

NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of DA-1241
PR NEWSWIRE
18 Jan 2024
Share Share
Zydus receives USFDA approval for ZITUVIO™ to treat type 2 diabetes mellitus

Zydus receives USFDA approval for ZITUVIO™ to treat type 2 diabetes mellitus
PR NEWSWIRE
20 Oct 2023
Share Share
Merck, Viatris agree to settle patent feud surrounding diabetes drugs

Merck, Viatris agree to settle patent feud surrounding diabetes drugs
Paul Schloesser ENDPTS
21 Mar 2023
Share Share
Pharma companies are launching generics of Sitagliptin post-patent expiry

Pharma companies are launching generics of Sitagliptin post-patent expiry
Sushmita Panda FINANCIALEXPRESS
26 Dec 2022
Share Share
Emmes acquires Clinical Edge; Expands global reach

Emmes acquires Clinical Edge; Expands global reach
PHARMABIZ
30 Sep 2022
Share Share
US Court of Appeals for Circuit Rules in Favor of Merck in Patent Lawsuit

US Court of Appeals for Circuit Rules in Favor of Merck in Patent Lawsuit
BUSINESSWIRE
29 Sep 2022
Share Share
Govt launches diabetes drug Sitagliptin, its combinations at Rs 60/pack of 10

Govt launches diabetes drug Sitagliptin, its combinations at Rs 60/pack of 10
THE PRINT
18 Sep 2022
Share Share